Clinical trial
An Open Label Optimization Study to Assess the Effectiveness of the SAINT® Neuromodulation System (NMS) to Treat Major Depressive Disorder
NCT05819021 is registered in ClinicalTrials.gov with Magnus Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Optimization Study to Assess the Effectiveness of the SAINT® Neuromodulation System (NMS) to Treat Major Depressive Disorder
- Lead sponsor
- Magnus Medical
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 6, 2023
- Completion date
- April 15, 2027
- Enrollment
- 1,000 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.